Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease
Recruiting
Observational Study
Graves Disease
Graves Ophthalmopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Elazıg Fethi Sekin Sehir Hastanesi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This retrospective observational study aims to evaluate the relationship between systemic inflammatory parameters, thyroid autoimmunity markers, and neuroretinal structures in patients with Graves disease. Medical records of patients diagnosed with Graves disease and healthy control subjects evaluated at Elazığ Fethi Sekin City Hospital between August 2018 and January 2026 will be reviewed. Optica…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
Diagnosis of Graves' disease (for the patient group)
No known thyroid disease in healthy control participants
Availability of optical coherence tomography (OCT) measurements and laboratory data
Time interval between OCT examination and blood sampling ≤ 10 da…
Contacts